nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Gadofosveset trisodium—ALB—chronic obstructive pulmonary disease	0.0122	0.5	CrCbGaD
Gadodiamide—Gadobenate Dimeglumine—ALB—chronic obstructive pulmonary disease	0.0122	0.5	CrCbGaD
Gadodiamide—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00248	0.00254	CcSEcCtD
Gadodiamide—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00247	0.00253	CcSEcCtD
Gadodiamide—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00245	0.00251	CcSEcCtD
Gadodiamide—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00245	0.00251	CcSEcCtD
Gadodiamide—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00243	0.0025	CcSEcCtD
Gadodiamide—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.00248	CcSEcCtD
Gadodiamide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00239	0.00245	CcSEcCtD
Gadodiamide—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00237	0.00243	CcSEcCtD
Gadodiamide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00236	0.00242	CcSEcCtD
Gadodiamide—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00234	0.0024	CcSEcCtD
Gadodiamide—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00234	0.0024	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00232	0.00238	CcSEcCtD
Gadodiamide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00232	0.00238	CcSEcCtD
Gadodiamide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00232	0.00238	CcSEcCtD
Gadodiamide—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00231	0.00237	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00231	0.00236	CcSEcCtD
Gadodiamide—Tremor—Montelukast—chronic obstructive pulmonary disease	0.0023	0.00235	CcSEcCtD
Gadodiamide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00227	0.00233	CcSEcCtD
Gadodiamide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00226	0.00231	CcSEcCtD
Gadodiamide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00226	0.00231	CcSEcCtD
Gadodiamide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00223	0.00228	CcSEcCtD
Gadodiamide—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00221	0.00227	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00219	0.00225	CcSEcCtD
Gadodiamide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00219	0.00225	CcSEcCtD
Gadodiamide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00213	0.00218	CcSEcCtD
Gadodiamide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00213	0.00218	CcSEcCtD
Gadodiamide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00213	0.00218	CcSEcCtD
Gadodiamide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00213	0.00218	CcSEcCtD
Gadodiamide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00213	0.00218	CcSEcCtD
Gadodiamide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00213	0.00218	CcSEcCtD
Gadodiamide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00213	0.00218	CcSEcCtD
Gadodiamide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00213	0.00218	CcSEcCtD
Gadodiamide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00212	0.00218	CcSEcCtD
Gadodiamide—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00212	0.00218	CcSEcCtD
Gadodiamide—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00212	0.00218	CcSEcCtD
Gadodiamide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00212	0.00217	CcSEcCtD
Gadodiamide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00212	0.00217	CcSEcCtD
Gadodiamide—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00212	0.00217	CcSEcCtD
Gadodiamide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.0021	0.00216	CcSEcCtD
Gadodiamide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.0021	0.00216	CcSEcCtD
Gadodiamide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00209	0.00214	CcSEcCtD
Gadodiamide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00209	0.00214	CcSEcCtD
Gadodiamide—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00208	0.00214	CcSEcCtD
Gadodiamide—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00208	0.00214	CcSEcCtD
Gadodiamide—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00208	0.00213	CcSEcCtD
Gadodiamide—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00208	0.00213	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00207	0.00212	CcSEcCtD
Gadodiamide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00204	0.00209	CcSEcCtD
Gadodiamide—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00204	0.00209	CcSEcCtD
Gadodiamide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00204	0.00209	CcSEcCtD
Gadodiamide—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00204	0.00209	CcSEcCtD
Gadodiamide—Infection—Formoterol—chronic obstructive pulmonary disease	0.00203	0.00208	CcSEcCtD
Gadodiamide—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00203	0.00208	CcSEcCtD
Gadodiamide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.00206	CcSEcCtD
Gadodiamide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.00206	CcSEcCtD
Gadodiamide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.00206	CcSEcCtD
Gadodiamide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00201	0.00206	CcSEcCtD
Gadodiamide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.002	0.00205	CcSEcCtD
Gadodiamide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.002	0.00205	CcSEcCtD
Gadodiamide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.002	0.00205	CcSEcCtD
Gadodiamide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.002	0.00205	CcSEcCtD
Gadodiamide—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.002	0.00205	CcSEcCtD
Gadodiamide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.002	0.00205	CcSEcCtD
Gadodiamide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00199	0.00204	CcSEcCtD
Gadodiamide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00199	0.00204	CcSEcCtD
Gadodiamide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00199	0.00204	CcSEcCtD
Gadodiamide—Infection—Montelukast—chronic obstructive pulmonary disease	0.00199	0.00204	CcSEcCtD
Gadodiamide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00198	0.00203	CcSEcCtD
Gadodiamide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00197	0.00202	CcSEcCtD
Gadodiamide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00196	0.00201	CcSEcCtD
Gadodiamide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00198	CcSEcCtD
Gadodiamide—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00198	CcSEcCtD
Gadodiamide—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00192	0.00196	CcSEcCtD
Gadodiamide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00191	0.00196	CcSEcCtD
Gadodiamide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00191	0.00196	CcSEcCtD
Gadodiamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.0019	0.00195	CcSEcCtD
Gadodiamide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.0019	0.00194	CcSEcCtD
Gadodiamide—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00189	0.00194	CcSEcCtD
Gadodiamide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00189	0.00194	CcSEcCtD
Gadodiamide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00188	0.00193	CcSEcCtD
Gadodiamide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00186	0.00191	CcSEcCtD
Gadodiamide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00186	0.00191	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00186	0.00191	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00186	0.00191	CcSEcCtD
Gadodiamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00184	0.00188	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00182	0.00187	CcSEcCtD
Gadodiamide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00182	0.00187	CcSEcCtD
Gadodiamide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00182	0.00187	CcSEcCtD
Gadodiamide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00182	0.00186	CcSEcCtD
Gadodiamide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00182	0.00186	CcSEcCtD
Gadodiamide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00185	CcSEcCtD
Gadodiamide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.0018	0.00184	CcSEcCtD
Gadodiamide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.0018	0.00184	CcSEcCtD
Gadodiamide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.0018	0.00184	CcSEcCtD
Gadodiamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00179	0.00183	CcSEcCtD
Gadodiamide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00178	0.00182	CcSEcCtD
Gadodiamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00177	0.00182	CcSEcCtD
Gadodiamide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00176	0.0018	CcSEcCtD
Gadodiamide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00176	0.0018	CcSEcCtD
Gadodiamide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00176	0.0018	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.0018	CcSEcCtD
Gadodiamide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00175	0.00179	CcSEcCtD
Gadodiamide—Pain—Formoterol—chronic obstructive pulmonary disease	0.00175	0.00179	CcSEcCtD
Gadodiamide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00177	CcSEcCtD
Gadodiamide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00172	0.00177	CcSEcCtD
Gadodiamide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00172	0.00176	CcSEcCtD
Gadodiamide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.00176	CcSEcCtD
Gadodiamide—Pain—Montelukast—chronic obstructive pulmonary disease	0.00171	0.00175	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00171	0.00175	CcSEcCtD
Gadodiamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00171	0.00175	CcSEcCtD
Gadodiamide—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.0017	0.00174	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.0017	0.00174	CcSEcCtD
Gadodiamide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.0017	0.00174	CcSEcCtD
Gadodiamide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00169	0.00173	CcSEcCtD
Gadodiamide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00169	0.00173	CcSEcCtD
Gadodiamide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00168	0.00172	CcSEcCtD
Gadodiamide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00168	0.00172	CcSEcCtD
Gadodiamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00168	0.00172	CcSEcCtD
Gadodiamide—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00168	0.00172	CcSEcCtD
Gadodiamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00167	0.00171	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00167	0.00171	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00167	0.00171	CcSEcCtD
Gadodiamide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00166	0.0017	CcSEcCtD
Gadodiamide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00165	0.00169	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00164	0.00168	CcSEcCtD
Gadodiamide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00162	0.00166	CcSEcCtD
Gadodiamide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00162	0.00166	CcSEcCtD
Gadodiamide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00161	0.00165	CcSEcCtD
Gadodiamide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00161	0.00165	CcSEcCtD
Gadodiamide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00161	0.00165	CcSEcCtD
Gadodiamide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00161	0.00165	CcSEcCtD
Gadodiamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00161	0.00165	CcSEcCtD
Gadodiamide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.0016	0.00164	CcSEcCtD
Gadodiamide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00159	0.00163	CcSEcCtD
Gadodiamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00159	0.00163	CcSEcCtD
Gadodiamide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00159	0.00163	CcSEcCtD
Gadodiamide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.00163	CcSEcCtD
Gadodiamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00158	0.00162	CcSEcCtD
Gadodiamide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00158	0.00162	CcSEcCtD
Gadodiamide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00158	0.00162	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00162	CcSEcCtD
Gadodiamide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00153	0.00157	CcSEcCtD
Gadodiamide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00156	CcSEcCtD
Gadodiamide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00156	CcSEcCtD
Gadodiamide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.00154	CcSEcCtD
Gadodiamide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.0015	0.00154	CcSEcCtD
Gadodiamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.0015	0.00154	CcSEcCtD
Gadodiamide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.0015	0.00154	CcSEcCtD
Gadodiamide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00147	0.00151	CcSEcCtD
Gadodiamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.0015	CcSEcCtD
Gadodiamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00146	0.0015	CcSEcCtD
Gadodiamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00144	0.00148	CcSEcCtD
Gadodiamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00144	0.00148	CcSEcCtD
Gadodiamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00147	CcSEcCtD
Gadodiamide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00146	CcSEcCtD
Gadodiamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00141	0.00145	CcSEcCtD
Gadodiamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00143	CcSEcCtD
Gadodiamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00143	CcSEcCtD
Gadodiamide—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00139	0.00143	CcSEcCtD
Gadodiamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00142	CcSEcCtD
Gadodiamide—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00138	0.00141	CcSEcCtD
Gadodiamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00137	0.0014	CcSEcCtD
Gadodiamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.0014	CcSEcCtD
Gadodiamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00138	CcSEcCtD
Gadodiamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00138	CcSEcCtD
Gadodiamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00136	CcSEcCtD
Gadodiamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00135	CcSEcCtD
Gadodiamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00133	CcSEcCtD
Gadodiamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00133	CcSEcCtD
Gadodiamide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00129	0.00132	CcSEcCtD
Gadodiamide—Rash—Formoterol—chronic obstructive pulmonary disease	0.00129	0.00132	CcSEcCtD
Gadodiamide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00129	0.00132	CcSEcCtD
Gadodiamide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00129	0.00132	CcSEcCtD
Gadodiamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00131	CcSEcCtD
Gadodiamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00131	CcSEcCtD
Gadodiamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00131	CcSEcCtD
Gadodiamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00127	0.0013	CcSEcCtD
Gadodiamide—Rash—Montelukast—chronic obstructive pulmonary disease	0.00126	0.00129	CcSEcCtD
Gadodiamide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00126	0.00129	CcSEcCtD
Gadodiamide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00129	CcSEcCtD
Gadodiamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00128	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00124	0.00127	CcSEcCtD
Gadodiamide—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00124	0.00127	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00124	0.00127	CcSEcCtD
Gadodiamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00126	CcSEcCtD
Gadodiamide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00122	0.00125	CcSEcCtD
Gadodiamide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00125	CcSEcCtD
Gadodiamide—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00122	0.00125	CcSEcCtD
Gadodiamide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00124	CcSEcCtD
Gadodiamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00124	CcSEcCtD
Gadodiamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00124	CcSEcCtD
Gadodiamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00124	CcSEcCtD
Gadodiamide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00119	0.00122	CcSEcCtD
Gadodiamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00122	CcSEcCtD
Gadodiamide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.0012	CcSEcCtD
Gadodiamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00117	CcSEcCtD
Gadodiamide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00114	0.00117	CcSEcCtD
Gadodiamide—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00115	CcSEcCtD
Gadodiamide—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00113	CcSEcCtD
Gadodiamide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00113	CcSEcCtD
Gadodiamide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00109	0.00112	CcSEcCtD
Gadodiamide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00108	0.00111	CcSEcCtD
Gadodiamide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00107	0.0011	CcSEcCtD
Gadodiamide—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00108	CcSEcCtD
Gadodiamide—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00104	CcSEcCtD
Gadodiamide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000993	0.00102	CcSEcCtD
Gadodiamide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000946	0.000969	CcSEcCtD
Gadodiamide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000914	0.000936	CcSEcCtD
Gadodiamide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000911	0.000934	CcSEcCtD
Gadodiamide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000888	0.00091	CcSEcCtD
Gadodiamide—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000883	0.000905	CcSEcCtD
Gadodiamide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000878	0.0009	CcSEcCtD
Gadodiamide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000865	0.000887	CcSEcCtD
Gadodiamide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000853	0.000874	CcSEcCtD
Gadodiamide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000838	0.000859	CcSEcCtD
Gadodiamide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000838	0.000859	CcSEcCtD
Gadodiamide—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000835	0.000856	CcSEcCtD
Gadodiamide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000828	0.000849	CcSEcCtD
Gadodiamide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000815	0.000835	CcSEcCtD
Gadodiamide—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000804	0.000824	CcSEcCtD
Gadodiamide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000804	0.000824	CcSEcCtD
Gadodiamide—Infection—Prednisone—chronic obstructive pulmonary disease	0.000798	0.000818	CcSEcCtD
Gadodiamide—Shock—Prednisone—chronic obstructive pulmonary disease	0.000791	0.00081	CcSEcCtD
Gadodiamide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000788	0.000808	CcSEcCtD
Gadodiamide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000784	0.000804	CcSEcCtD
Gadodiamide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000777	0.000796	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000732	0.00075	CcSEcCtD
Gadodiamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000731	0.00075	CcSEcCtD
Gadodiamide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000722	0.00074	CcSEcCtD
Gadodiamide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000707	0.000725	CcSEcCtD
Gadodiamide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000697	0.000715	CcSEcCtD
Gadodiamide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000697	0.000714	CcSEcCtD
Gadodiamide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000693	0.00071	CcSEcCtD
Gadodiamide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000693	0.00071	CcSEcCtD
Gadodiamide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000662	0.000679	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000657	0.000674	CcSEcCtD
Gadodiamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000657	0.000673	CcSEcCtD
Gadodiamide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000638	0.000654	CcSEcCtD
Gadodiamide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000635	0.000651	CcSEcCtD
Gadodiamide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000635	0.000651	CcSEcCtD
Gadodiamide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000592	0.000607	CcSEcCtD
Gadodiamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000577	0.000591	CcSEcCtD
Gadodiamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000569	0.000583	CcSEcCtD
Gadodiamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00055	0.000564	CcSEcCtD
Gadodiamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000531	0.000545	CcSEcCtD
Gadodiamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000511	0.000524	CcSEcCtD
Gadodiamide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000507	0.000519	CcSEcCtD
Gadodiamide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000506	0.000519	CcSEcCtD
Gadodiamide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000503	0.000516	CcSEcCtD
Gadodiamide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000477	0.000489	CcSEcCtD
